Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Cellular Immunology|June 10, 2017
Direct control of B cells by Tregs: An opportunity for long-term modulation of the humoral responseElizabeth Weingartner, Amit GoldingAccess Microbiology|September 25, 2020
Antiphospholipid antibody syndrome with thrombotic splenic infarcts associated with acute cytomegalovirus infectionChristopher Denham, Ginger Tissier, Amit GoldingLupus Science & Medicine|November 7, 2018
Cytoplasmic FOXO1 identifies a novel disease-activity associated B cell phenotype in SLEMolly K Hritzo Ahye, Amit GoldingJournal of Immunological Methods|January 17, 2018
Imaging flow cytometry: A method for examining dynamic native FOXO1 localization in human lymphocytesMolly K Hritzo, Jean-Paul Courneya, Amit GoldingRheumatic Diseases Clinics of North America|May 15, 2007
Rheumatoid arthritis and reproductionAmit Golding, Uzma J Haque, Jon T GilesJournal of Immunological Methods|November 17, 2016
A novel method for assaying human regulatory T cell direct suppression of B cell effector functionElizabeth Weingartner, Jean-Paul Courneya, Achsah Keegan, et al.Arthritis and Rheumatism|August 9, 2013
The percentage of FoxP3+Helios+ Treg cells correlates positively with disease activity in systemic lupus erythematosusAmit Golding, Sarfaraz Hasni, Gabor Illei, et al.Immunology|May 15, 2010
Interferon-alpha regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responsesAmit Golding, Antony Rosen, Michelle Petri, et al.Immunohorizons|June 26, 2019
Semaphorin 4A Stabilizes Human Regulatory T Cell Phenotype via Plexin B1Svetlana P Chapoval, Molly Hritzo, Xiulan Qi, et al.Journal of Clinical Pharmacology|August 12, 2020
Immunomodulatory Therapeutic Proteins in COVID-19: Current Clinical Development and Clinical Pharmacology ConsiderationsPing Ji, Jianmeng Chen, Amit Golding, et al.Pageof 2